The trial conducted in Durban, South Africa, showed that 20 per cent of participants remain off ART and are virally suppressed after one-and-a-half years, according to a press statement from the ...

The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments.

In a moment of both triumph and uncertainty, South Africa's scientific community has unveiled encouraging results from a landmark HIV cure trial conducted in Durban, KwaZulu-Natal. The University of ...

The results of a groundbreaking trial carried out in Durban to find a cure for HIV are showing promise, scientists say.

The results of a groundbreaking trial carried out in Durban to find a cure for HIV are showing promise, scientists say.

It was sent to 2,500 patients who had potentially been exposed to bloodborne viruses including HIV, hepatitis B, and hepatitis C due to what the agency described as a failure to properly clean ...

Antiretroviral therapy (ART) is under continuous development with the goal of long-term control of HIV replication using effective and well-tolerated drugs. On 29 February 2024, the WHO published an ...

CVD risk is reduced in those with a higher CD4 + T-cell count and lower HIV RNA. Exposure to some, but not all, ART is associated with increased risk of MI and CVD. Pathogenesis of Increased CVD ...

Health Minister, Dr Aaron Motsoaledi will on Tuesday, 25 February lead the official launch of new HIV treatment campaign with the objective to close the gap by putting additional 1.1 million people ...

Investigating the relationship between IL-1 and inflammation in inflammatory bowel disease (IBD), researchers unveiled mesenchyme homeobox 1 (MEOX1), an IL-1-dependent transcription factor that is ...